• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE PROA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE PROA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1128350-38
Device Problems Difficult to Remove (1528); Material Separation (1562)
Patient Problem High Blood Pressure/ Hypertension (1908)
Event Date 09/22/2019
Event Type  Injury  
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation determined the reported difficulties and treatment appear to be related to circumstances of the procedure as it is likely the device met resistance with the guide wire and guide catheter during removal causing the reported difficulty to remove.The balloon separated from the stent delivery system during the difficult removal resulting in the reported material separation.The reported hypertension and treatments appear to be related to operational context of the procedure.The reported patient effect of hypertension is listed in the xience alpine everolimus eluting coronary stent systems instructions for use (ifu) as a known patient effect of coronary stenting procedures.Additionally, the reported death appears to be related to the patient¿s overall condition and is considered unrelated to the xience pro a device.There is no indication of a product quality issue with respect to manufacture, design or labeling.The xience pro a device is currently not commercially available; however, it is similar to a device sold in the u.S.
 
Event Description
Notification was received from bfarm that indicated: the public prosecutor¿s office reported a procedure in 2019, that involved four xience proa stents, three were implanted without issue.The 4th 3.50x38mm had a reported deflation issue.During removal the device separated and the patient then died.An autopsy revealed a 32cm long catheter section with a balloon was found in the aorta up to the heart valves.A follow-up call to bfarm provided hospital name and advised dr.(b)(6) performed the procedure.The first notification to abbott was from bfarm on nov 9, 2020, which is why this event was not recorded in 2019.Further follow up with dr.(b)(6) confirmed the complaint was not reported to abbott during the time of the incident as she did not identify a device issue had occurred.She confirms that there was no deflation issue noted with the complaint device and no allegation against abbott.Per the physician¿s opinion, the patient died because of procedural circumstances and the state of the patient¿s overall condition.The patient had a history of st-elevation myocardial infraction (stemi) with coronary three-vessel disease, severe stenosis riva and proximal rcx and had previously suffered a myocardial infarction.Abbott was unable to perform an investigation of the device as it was never returned.Due to physician¿s statement, and the separated device being discarded, there is no indication that the event meets the definition of a reportable event per vorkommnis 29 of the mpg and is not reportable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PROA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key10943178
MDR Text Key219494963
Report Number2024168-2020-10166
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/07/2022
Device Catalogue Number1128350-38
Device Lot Number9032161
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/09/2020
Initial Date FDA Received12/03/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/08/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
2.75X15MM XIENCE PROA; 2.75X18MM XIENCE PROA; 3.0X33MM XIENCE PROA
Patient Outcome(s) Required Intervention;
-
-